Corix Bioscience Net Worth
Corix Bioscience Net Worth Breakdown | CXBS |
Corix Bioscience Net Worth Analysis
Corix Bioscience's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Corix Bioscience's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Corix Bioscience's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Corix Bioscience's net worth analysis. One common approach is to calculate Corix Bioscience's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Corix Bioscience's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Corix Bioscience's net worth. This approach calculates the present value of Corix Bioscience's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Corix Bioscience's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Corix Bioscience's net worth. This involves comparing Corix Bioscience's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Corix Bioscience's net worth relative to its peers.
To determine if Corix Bioscience is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Corix Bioscience's net worth research are outlined below:
| Corix Bioscience generated a negative expected return over the last 90 days | |
| Corix Bioscience has some characteristics of a very speculative penny stock | |
| Corix Bioscience has a very high chance of going through financial distress in the upcoming years | |
| Corix Bioscience currently holds 5.08 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Corix Bioscience has a current ratio of 0.16, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Corix Bioscience's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 693.62 K. Net Loss for the year was (4.43 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Corix Bioscience currently holds about 360.87 K in cash with (1.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from thelincolnianonline.com: LiveOne versus Kuke Music Head-To-Head Comparison |
Follow Corix Bioscience's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 820.28 K.Evaluate Corix Bioscience's management efficiency
Total Assets is likely to drop to about 7.6 M in 2025. Net Tangible Assets is likely to drop to about 3.3 M in 2025Corix Bioscience's management efficiency ratios could be used to measure how well Corix Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Corix Bioscience's management has consistently demonstrated strong leadership, driving both financial growth and operational excellence. By analyzing current market trends and future growth opportunities, we assess the stock's true value and potential for investors.
Enterprise Value Revenue 0.701 |
Corix Bioscience Earnings per Share Projection vs Actual
Additional Tools for Corix Stock Analysis
When running Corix Bioscience's price analysis, check to measure Corix Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corix Bioscience is operating at the current time. Most of Corix Bioscience's value examination focuses on studying past and present price action to predict the probability of Corix Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corix Bioscience's price. Additionally, you may evaluate how the addition of Corix Bioscience to your portfolios can decrease your overall portfolio volatility.